{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:59:46Z","timestamp":1792897186756,"version":"4.5.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T00:00:00Z","timestamp":1269388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00774-010-0162-7","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T07:17:09Z","timestamp":1269328629000},"page":"365-383","source":"Crossref","is-referenced-by-count":224,"title":["Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons"],"prefix":"10.1007","volume":"28","author":[{"given":"Toshiyuki","family":"Yoneda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hagino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Soen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Toyosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Urade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,24]]},"reference":[{"key":"162_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","volume":"1117","author":"RG Russell","year":"2007","unstructured":"Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209\u2013257","journal-title":"Ann N Y Acad Sci"},{"key":"162_CR2","first-page":"356","volume":"7","author":"LK McCauley","year":"2007","unstructured":"McCauley LK, Li X (2007) Distinguishing features of the oral cavity and its predisposition to osteonecrosis. J Musculoskelet Neuronal Interact 7:356\u2013357","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"162_CR3","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","volume":"65","author":"RE Marx","year":"2007","unstructured":"Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65:2397\u20132410","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ar.20619","volume":"291","author":"SS Huja","year":"2008","unstructured":"Huja SS, Beck FM (2008) Bone remodeling in maxilla, mandible, and femur of young dogs. Anat Rec 291:1\u20135","journal-title":"Anat Rec"},{"key":"162_CR5","doi-asserted-by":"crossref","unstructured":"Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws (2007) American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369\u2013376","DOI":"10.1016\/j.joms.2006.11.003"},{"issue":"5 Suppl","key":"162_CR6","first-page":"2","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, American Association of Oral, Maxillofacial Surgeons (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20132009 update. J Oral Maxillofac Surg 67(5 Suppl):2\u201312","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.joms.2008.09.028","volume":"67","author":"S Otto","year":"2009","unstructured":"Otto S, Hafner S, Gr\u00f6tz KA (2009) The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg 67:589\u2013592","journal-title":"J Oral Maxillofac Surg"},{"issue":"5 Suppl","key":"162_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.joms.2009.01.003","volume":"67","author":"LA Assael","year":"2009","unstructured":"Assael LA (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 67(5 Suppl):35\u201343","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5005\/jcdp-8-3-53","volume":"8","author":"YM Nusair","year":"2007","unstructured":"Nusair YM, Younis MH (2007) Prevalence, clinical picture, and risk factors of dry socket in a Jordanian dental teaching center. J Contemp Dent Pract 8:53\u201363","journal-title":"J Contemp Dent Pract"},{"key":"162_CR10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"SB Woo","year":"2006","unstructured":"Woo SB, Hellstein JW, Kalmar JR (2006) Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753\u2013761","journal-title":"Ann Intern Med"},{"key":"162_CR11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","volume":"23","author":"AO Hoff","year":"2008","unstructured":"Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23:826\u2013836","journal-title":"J Bone Miner Res"},{"key":"162_CR12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jnci\/djm025","volume":"99","author":"GS Wilkinson","year":"2007","unstructured":"Wilkinson GS, Kuo YF, Freeman JL, Goodwin JS (2007) Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis. J Natl Cancer Inst 99:1016\u20131024","journal-title":"J Natl Cancer Inst"},{"key":"162_CR13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","volume":"44","author":"T Boonyapakorn","year":"2008","unstructured":"Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G (2008) Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44:857\u2013869","journal-title":"Oral Oncol"},{"key":"162_CR14","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","volume":"23","author":"A Bamias","year":"2005","unstructured":"Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23:8580\u20138587","journal-title":"J Clin Oncol"},{"key":"162_CR15","first-page":"E456","volume":"11","author":"R Estefania Fresco","year":"2006","unstructured":"Estefania Fresco R, Ponte Fernandez R, Aguirre Urizar JM (2006) Bisphosphonates and oral pathology II. Osteonecrosis of the jaws: review of the literature before 2005. Med Oral Patol Oral Cir Bucal 11:E456\u2013E461","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"162_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"BG Durie","year":"2005","unstructured":"Durie BG, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353:99\u2013102","journal-title":"N Engl J Med"},{"key":"162_CR17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"M Maerevoet","year":"2005","unstructured":"Maerevoet M, Martin C, Duck L (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353:99\u2013102","journal-title":"N Engl J Med"},{"key":"162_CR18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415\u2013423","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa0806285","volume":"360","author":"M Gnant","year":"2009","unstructured":"Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, P\u00f6stlberger S et al (2009) Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 360:679\u2013691","journal-title":"N Engl J Med"},{"key":"162_CR20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3816\/CBC.2009.n.015","volume":"9","author":"AM Brufsky","year":"2009","unstructured":"Brufsky AM, Bosserman LD, Caradonna RR, Haley BB, Jones CM, Moore HC, Jin L, Warsi GM, Ericson SG, Perez EA (2009) Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results. Clin Breast Cancer 9:77\u201385","journal-title":"Clin Breast Cancer"},{"key":"162_CR21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14219\/jada.archive.2008.0017","volume":"139","author":"JT Grbic","year":"2008","unstructured":"Grbic JT, Landesberg R, Lin SO, Mesenbrink P, Teid IR, Leung PC, Casas N, Recknor CP, Hua Y, Delmas PD, Eriksen EF (2008) Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yeary pivotal fracture trial. J Am Dent Assoc 139:32\u201340","journal-title":"J Am Dent Assoc"},{"key":"162_CR22","first-page":"3078","volume":"103","author":"D Felsenberg","year":"2006","unstructured":"Felsenberg D, Hoffmeister B, Amling M, Seibel MJ, Fratzl P (2006) Kiefernekrosen nach hoch dosierter bisphosphonattherapie. Dtsch Arzebl 103:3078\u20133081","journal-title":"Dtsch Arzebl"},{"key":"162_CR23","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.14219\/jada.archive.2008.0110","volume":"139","author":"BJ Edwards","year":"2008","unstructured":"Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA (2008) American Dental Association Council on Scientific Affairs Expert Panel on Bisphosphonate-Associated Osteonecrosis of the Jaw. Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 139:1674\u20131677","journal-title":"J Am Dent Assoc"},{"key":"162_CR24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3174\/ajnr.A0518","volume":"28","author":"PM Phal","year":"2007","unstructured":"Phal PM, Myall RW, Assael LA, Weissman JL (2007) Imaging findings of bisphosphonate-associated osteonecrosis of the jaws. AJNR Am J Neuroradiol 28:1139\u20131145","journal-title":"AJNR Am J Neuroradiol"},{"key":"162_CR25","unstructured":"Marx RE (2006) Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws: history, etiology, prevention, and treatment. Quintessence Publishing, Carol Stream, IL"},{"key":"162_CR26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1259\/dmfr\/27458726","volume":"35","author":"S Chiandussi","year":"2006","unstructured":"Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R (2006) Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 35:236\u2013243","journal-title":"Dentomaxillofac Radiol"},{"key":"162_CR27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tripleo.2007.01.040","volume":"104","author":"SD Bianchi","year":"2007","unstructured":"Bianchi SD, Scoletta M, Cassione FB, Migliaretti G, Mozzati M (2007) Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:249\u2013258","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"162_CR28","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1078-0432.CCR-07-1430","volume":"14","author":"N Raje","year":"2008","unstructured":"Raje N, Woo SB, Hande K, Yap JT, Richardson PG et al (2008) Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res 14:2387\u20132395","journal-title":"Clin Cancer Res"},{"key":"162_CR29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1601-0825.2008.01494.x","volume":"15","author":"N Treister","year":"2009","unstructured":"Treister N, Sheehy N, Bae EH, Friedland B, Lerman M, Woo S (2009) Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws. Oral Dis 15:88\u201392","journal-title":"Oral Dis"},{"key":"162_CR30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","volume":"105","author":"A Bedogni","year":"2008","unstructured":"Bedogni A, Blandamura S, Lokmic Z, Palumbo C, Ragazzo M, Ferrari F, Tregnaghi A, Pietrogrande F, Procopio O, Saia G, Ferretti M, Bedogni G, Chiarini L, Ferronato G, Ninfo V, Lo Russo L, Lo Muzio L, Nocini PF (2008) Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:358\u2013364","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"162_CR31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.crad.2007.04.023","volume":"63","author":"S Bisdas","year":"2008","unstructured":"Bisdas S, Chambron Pinho N, Smolarz A, Sader R, Vogl TJ, Mack MG (2008) Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. Clin Radiol 63:71\u201377","journal-title":"Clin Radiol"},{"key":"162_CR32","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR et al (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491","journal-title":"J Bone Miner Res"},{"key":"162_CR33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.joms.2008.09.031","volume":"67","author":"H Mawardi","year":"2009","unstructured":"Mawardi H, Treister N, Richardson P, Anderson K, Munshi N, Faiella RA, Woo SB (2009) Sinus tracts\u2014an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg 67:593\u2013601","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2214\/AJR.07.3045","volume":"190","author":"L Garcia-Ferrer","year":"2008","unstructured":"Garcia-Ferrer L, Bagin JV, Martinez-Sanjuan V, Hernandez-Bazan S, Garcia R, Jiminez-Soriano Y, Hervas V (2008) MRI of mandibular osteonecrosis secondary to bisphosphonates. AJR Am J Roentgenol 190:949\u2013955","journal-title":"AJR Am J Roentgenol"},{"key":"162_CR35","first-page":"177","volume":"10","author":"A Zanglis","year":"2007","unstructured":"Zanglis A, Andreopoulos D, Dima M, Baltas G, Baziotis N (2007) Jaw uptake of technetium-99 methylene diphosphonate in patients on biphosphonates: a word of caution. Hell J Nucl Med 10:177\u2013180","journal-title":"Hell J Nucl Med"},{"key":"162_CR36","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.joms.2009.03.005","volume":"67","author":"FS O\u2019Ryan","year":"2009","unstructured":"O\u2019Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, Martin D, Liberty D, Lo JC (2009) Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. J Oral Maxillofac Surg 67:1363\u20131372","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/RLU.0b013e318148b636","volume":"33","author":"L Ho","year":"2008","unstructured":"Ho L, Quan V, Henderson R (2008) Zoledronate-related osteonecrosis of the mandible. Clin Nucl Med 33:68\u201370","journal-title":"Clin Nucl Med"},{"key":"162_CR38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/RCT.0b013e31817e4986","volume":"33","author":"A Krishnan","year":"2009","unstructured":"Krishnan A, Arslanoglu A, Yildirm N, Silbergleit R, Aygun N (2009) Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings. J Comput Assist Tomogr 33:298\u2013304","journal-title":"J Comput Assist Tomogr"},{"key":"162_CR39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","volume":"35","author":"T Hansen","year":"2006","unstructured":"Hansen T, Kunkel M, Weber A, James Kirkpatrick C (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates: histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155\u2013160","journal-title":"J Oral Pathol Med"},{"key":"162_CR40","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMcpc0800341","volume":"358","author":"TB Dodson","year":"2008","unstructured":"Dodson TB, Raje NS, Caruso PA, Rosenberg AE (2008) Case records of the Massachusetts General Hospital Case 9\u20132008. A 65-year-old woman with a nonhealing ulcer of the jaw. N Engl J Med 358:1283\u20131291","journal-title":"N Engl J Med"},{"key":"162_CR41","first-page":"350","volume":"7","author":"HK Kim","year":"2007","unstructured":"Kim HK (2007) Introduction to osteonecrosis of the femoral head (OFH) and osteonecrosis of the jaw (ONJ). J Musculoskelet Neuronal Interact 7:350\u2013353","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"162_CR42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ncponc1000","volume":"4","author":"F Bertoldo","year":"2007","unstructured":"Bertoldo F, Santini D, Lo Cascio V (2007) Bisphosphonates, osteomyelitis of the jaw: a pathogenic puzzle. Nat Clin Pract Oncol 4:711\u2013721","journal-title":"Nat Clin Pract Oncol"},{"key":"162_CR43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00428-007-0516-2","volume":"451","author":"T Hansen","year":"2007","unstructured":"Hansen T, Kunkel M, Springer E, Walter C, Weber A, Siegel E, Kirkpatrick CJ (2007) Actinomycosis of the jaws\u2014histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch 451:1009\u20131017","journal-title":"Virchows Arch"},{"key":"162_CR44","doi-asserted-by":"crossref","unstructured":"Hansen T, Kirkpatrick CJ, Walter C, Kunkel M (2006) Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate-associated osteonecrosis: a paradoxical observation? Virchows Arch 449:448\u2013454","DOI":"10.1007\/s00428-006-0261-y"},{"key":"162_CR45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","volume":"339","author":"KG Saag","year":"1998","unstructured":"Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292\u2013299","journal-title":"N Engl J Med"},{"key":"162_CR46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bone.2009.05.008","volume":"45","author":"G Favio","year":"2009","unstructured":"Favio G, Piilloli GP, Maiorano E (2009) Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy. Bone (NY) 45:406\u2013413","journal-title":"Bone (NY)"},{"key":"162_CR47","first-page":"6538","volume":"62","author":"P Fournier","year":"2002","unstructured":"Fournier P, Boissier S, Filleur S, Guglielmi J, Cabon F, Colombel M, Clezardin P (2002) Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62:6538\u20136544","journal-title":"Cancer Res"},{"key":"162_CR48","first-page":"1080","volume":"8","author":"D Santini","year":"2002","unstructured":"Santini D, Vincenzi B, Avvisati G, Dicuonzo G, Battistoni F, Gavasci M, Salerno A, Denaro V, Tonini G (2002) Pamidronate induces modifications of circulating angiogenetic factors in cancer patients. Clin Cancer Res 8:1080\u20131084","journal-title":"Clin Cancer Res"},{"key":"162_CR49","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR50","doi-asserted-by":"crossref","unstructured":"Hoefert S, Schmitz I, Tannapfel A, Eufinger H (2009) Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin Oral Invest (in press)","DOI":"10.1007\/s00784-009-0300-6"},{"key":"162_CR51","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.jbiomech.2005.06.006","volume":"39","author":"JG Hazenberg","year":"2006","unstructured":"Hazenberg JG, Freeley M, Foran E, Lee TC, Taylor D (2006) Microdamage: a cell-transducing mechanism based on ruptured osteocyte processes. J Biomech 39:2096\u20132103","journal-title":"J Biomech"},{"key":"162_CR52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1359\/jbmr.090203","volume":"24","author":"S Baim","year":"2009","unstructured":"Baim S, Miller PD (2009) Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. J Bone Miner Res 24:561\u2013574","journal-title":"J Bone Miner Res"},{"key":"162_CR53","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.joms.2008.01.054","volume":"66","author":"S Khosla","year":"2008","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR et al (2008) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 66:1320\u20131321","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR54","first-page":"159","volume":"67","author":"S Lehrer","year":"2008","unstructured":"Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, Kogan R (2008) Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 67:159\u2013161","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5 Suppl","key":"162_CR55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2009.01.011","volume":"67","author":"JE Fantasia","year":"2009","unstructured":"Fantasia JE (2009) Bisphosphonates\u2014what the dentist needs to know: practical considerations. J Oral Maxillofac Surg 67(5 Suppl):53\u201360","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR56","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","volume":"24","author":"A Badros","year":"2006","unstructured":"Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, Fenton R, Gahres N, Sausville E, Ord R, Meiller T (2006) Osteonecrosis of the jaw in multiple myeloma patients. Clinical features and risk factors. J Clin Oncol 24:945\u2013952","journal-title":"J Clin Oncol"},{"key":"162_CR57","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR58","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR59","first-page":"349","volume":"21","author":"MK Jeffcoat","year":"2006","unstructured":"Jeffcoat MK (2006) Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants 21:349\u2013353","journal-title":"Int J Oral Maxillofac Implants"},{"key":"162_CR60","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.joms.2007.12.040","volume":"66","author":"BM Bell","year":"2008","unstructured":"Bell BM, Bell RE (2008) Oral bisphosphonates and dental implants: a retrospective study. J Oral Maxillofac Surg 66:1022\u20131024","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.joms.2007.09.019","volume":"66","author":"BT Grant","year":"2008","unstructured":"Grant BT, Amenedo C, Freeman K, Kraut RA (2008) Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg 66:223\u2013230","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR62","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","volume":"92","author":"M Khamaisi","year":"2007","unstructured":"Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, Elad S (2007) Possible association between diabetes and bisphosphonate-related jaw osteonecrosis. J Clin Endocrinol Metab 92:1172\u20131175","journal-title":"J Clin Endocrinol Metab"},{"key":"162_CR63","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","volume":"66","author":"JH Wessel","year":"2008","unstructured":"Wessel JH, Dodson TB, Zavras AI (2008) Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study. J Oral Maxillofac Surg 66:625\u2013631","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.joms.2008.09.015","volume":"67","author":"S Lehrer","year":"2009","unstructured":"Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, Kogan R (2009) Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene. J Oral Maxillofac Surg 67:159\u2013161","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR65","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","volume":"112","author":"ME Sarasquete","year":"2008","unstructured":"Sarasquete ME, Garcia-Sanz R, Marin L, Alcoceba M, Chillon MC, Balanzategui A, Santamaria C, Rosinol L, de la Rubia J, Hernandez MT, Garcia-Navarro I, Lahuerta JJ, Gonzalez M, San Miguel JF (2008) Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis. Blood 112:2709\u20132712","journal-title":"Blood"},{"key":"162_CR66","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-051X.2005.00842.x","volume":"32","author":"G Ficarra","year":"2005","unstructured":"Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P, Pini Prato G (2005) Osteonecrosis of the jaw in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32:1123\u20131128","journal-title":"J Clin Periodontol"},{"key":"162_CR67","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.don.0000182737.09980.2c","volume":"31","author":"AP Sarathy","year":"2005","unstructured":"Sarathy AP, Bourgeois SL Jr, Goodell GG (2005) Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports. J Endod 31:759\u2013763","journal-title":"J Endod"},{"key":"162_CR68","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","volume":"7","author":"CA Migliorati","year":"2006","unstructured":"Migliorati CA, Siegel MA, Elting LS (2006) Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 7:508\u2013514","journal-title":"Lancet Oncol"},{"key":"162_CR69","first-page":"103","volume":"37","author":"L Palomo","year":"2006","unstructured":"Palomo L, Bissada N, Liu J (2006) Bisphosphonate therapy for bone loss in patients with osteoporosis and periodontal disease: clinical perspectives and review of the literature. Quintessence Int 37:103\u2013107","journal-title":"Quintessence Int"},{"issue":"5 Suppl","key":"162_CR70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.joms.2008.12.004","volume":"67","author":"TB Dodson","year":"2009","unstructured":"Dodson TB (2009) Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67(5 Suppl):44\u201352","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR71","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1902\/jop.2006.050187","volume":"77","author":"KM Soileau","year":"2006","unstructured":"Soileau KM (2006) Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy. J Periodontol 77:738\u2013743","journal-title":"J Periodontol"},{"key":"162_CR72","first-page":"1391","volume":"35","author":"AA Khan","year":"2008","unstructured":"Khan AA, Sandor GK, Dore E, Morrison AD, Alsahli M et al (2008) Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 35:1391\u20131397","journal-title":"J Rheumatol"},{"key":"162_CR73","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","volume":"42","author":"R Rizzoli","year":"2008","unstructured":"Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY (2008) Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone (NY) 42:841\u2013847","journal-title":"Bone (NY)"},{"key":"162_CR74","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bone.2006.11.023","volume":"40","author":"C Dannemann","year":"2007","unstructured":"Dannemann C, Grtz KW, Riener MO, Zwahlen RA (2007) Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder. Bone (NY) 40:828\u2013834","journal-title":"Bone (NY)"},{"issue":"5 Suppl","key":"162_CR75","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","volume":"67","author":"MR Allen","year":"2009","unstructured":"Allen MR, Burr DB (2009) The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 67(5 Suppl):61\u201370","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR76","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","volume":"66","author":"PP Sedghizadeh","year":"2008","unstructured":"Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW (2008) Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg 66:767\u2013775","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR77","doi-asserted-by":"crossref","unstructured":"Kobayashi Y, Hiraga T, Ueda A, Wang L, Matsumoto-Nakano M, Hata K, Yatani H, Yoneda T (2010) Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, with causing no osteonecrosis of the jaw in mice. J Bone Miner Metab (in press)","DOI":"10.1007\/s00774-009-0128-9"},{"key":"162_CR78","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","volume":"302","author":"J Wood","year":"2002","unstructured":"Wood J, Bonjean K, Ruetz S, Bellahc\u00e8ne A, Devy L, Foidart JM, Castronovo V, Green JR (2002) Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302:1055\u20131061","journal-title":"J Pharmacol Exp Ther"},{"key":"162_CR79","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","volume":"26","author":"CL Estilo","year":"2008","unstructured":"Estilo CL, Fornier M, Farooki A, Carlson D, Bohle G 3rd, Huryn JM (2008) Osteonecrosis of the jaw related to bevacizumab. J Clin Oncol 26:4037\u20134038","journal-title":"J Clin Oncol"},{"key":"162_CR80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","volume":"41","author":"IR Reid","year":"2007","unstructured":"Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone (NY) 41:318\u2013320","journal-title":"Bone (NY)"},{"key":"162_CR81","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","volume":"66","author":"R Landesberg","year":"2008","unstructured":"Landesberg R, Cozin M, Cremers S, Woo V, Kousteni S, Sinha S, Garrett-Sinha L, Raghavan S (2008) Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 66:839\u2013847","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR82","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","volume":"44","author":"IR Reid","year":"2009","unstructured":"Reid IR (2009) Osteonecrosis of the jaw: who gets it, and why? Bone (NY) 44:4\u201310","journal-title":"Bone (NY)"},{"key":"162_CR83","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.joms.2008.01.038","volume":"66","author":"MR Allen","year":"2008","unstructured":"Allen MR, Burr DB (2008) Mandible matrix necrosis in beagle dogs after 3\u00a0years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 66:987\u2013994","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR84","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.oraloncology.2008.04.013","volume":"45","author":"ST Sonis","year":"2009","unstructured":"Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC (2009) Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol 45:164\u2013172","journal-title":"Oral Oncol"},{"key":"162_CR85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"CI Ripamonti","year":"2009","unstructured":"Ripamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, Bareggi C, Ascani L, Cislaghi E (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 20:137\u2013145","journal-title":"Ann Oncol"},{"key":"162_CR86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","volume":"20","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, Migkou M, Eleftherakis-Papaiakovou E, Christoulas D, Terpos E, Bamias A (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20:117\u2013120","journal-title":"Ann Oncol"},{"key":"162_CR87","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/B978-012098652-1\/50180-3","volume-title":"Principles of bone biology","author":"H Fleisch","year":"2002","unstructured":"Fleisch H, Reszka A, Rodan G, Rogers M (2002) Bisphosphonates: mechanisms of action. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of bone biology, 2nd edn. Academic Press, San Diego, pp 1361\u20131385","edition":"2"},{"key":"162_CR88","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/annonc\/mdn796","volume":"20","author":"E Terpos","year":"2009","unstructured":"Terpos E, Sezer O, Croucher PI, Garc\u00eda-Sanz R, Boccadoro M, San Miguel J, Ashcroft J, Blad\u00e9 J, Cavo M, Delforge M, Dimopoulos MA, Facon T, Macro M, Waage A, Sonneveld P (2009) The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network. Ann Oncol 20:1303\u20131317","journal-title":"Ann Oncol"},{"key":"162_CR89","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377\u20131385","journal-title":"Lancet"},{"key":"162_CR90","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/sj.bjc.6601437","volume":"89","author":"JE Brown","year":"2003","unstructured":"Brown JE, Thomson CS, Ellis SP, Gutcher SA, Purohit OP, Coleman RE (2003) Bone resorption predicts for skeletal complications in metastatic bone disease. Br J Cancer 89:2031\u20132037","journal-title":"Br J Cancer"},{"key":"162_CR91","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jpeds.2008.05.003","volume":"153","author":"C Chahine","year":"2008","unstructured":"Chahine C, Cheung MS, Head TW, Schwartz S, Glorieux FH, Rauch F (2008) Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. J Pediatr 153:719\u2013720","journal-title":"J Pediatr"},{"key":"162_CR92","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0714.2007.00607.x","volume":"37","author":"B Malmgren","year":"2008","unstructured":"Malmgren B, Astrom E, Soderhall S (2008) No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J Oral Pathol Med 37:196\u2013200","journal-title":"J Oral Pathol Med"},{"key":"162_CR93","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00198-008-0604-4","volume":"19","author":"JR Curtis","year":"2008","unstructured":"Curtis JR, Westfall AO, Cheng H, Delzell E, Saag KG (2008) Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday. Osteoporos Int 19:1613\u20131620","journal-title":"Osteoporos Int"},{"key":"162_CR94","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.14219\/jada.archive.2005.0110","volume":"136","author":"MD Melo","year":"2005","unstructured":"Melo MD, Obeid G (2005) Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition. J Am Dent Assoc 136:1675\u20131681","journal-title":"J Am Dent Assoc"},{"key":"162_CR95","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","volume":"104","author":"CA Migliorati","year":"2005","unstructured":"Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer (Phila) 104:83\u201393","journal-title":"Cancer (Phila)"},{"issue":"5 Suppl","key":"162_CR96","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","volume":"67","author":"ER Carlson","year":"2009","unstructured":"Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67(5 Suppl):85\u201395","journal-title":"J Oral Maxillofac Surg"},{"issue":"5 Suppl","key":"162_CR97","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.joms.2008.12.007","volume":"67","author":"RE Marx","year":"2009","unstructured":"Marx RE (2009) Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws. J Oral Maxillofac Surg 67(5 Suppl):107\u2013119","journal-title":"J Oral Maxillofac Surg"},{"issue":"5 Suppl","key":"162_CR98","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.joms.2008.12.003","volume":"67","author":"JJ Freiberger","year":"2009","unstructured":"Freiberger JJ (2009) Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67(5 Suppl):96\u2013106","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR99","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","volume":"65","author":"RP Harper","year":"2007","unstructured":"Harper RP, Fung E (2007) Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH (1\u201334)]. J Oral Maxillofac Surg 65:573\u2013580","journal-title":"J Oral Maxillofac Surg"},{"key":"162_CR100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000110804","volume":"118","author":"A Timura\u011fao\u011flu","year":"2007","unstructured":"Timura\u011fao\u011flu A, Ozkaynak C, Tuzuner S, Bostan F, Undar L (2007) Improvement of zoledronic-acid-induced jaw osteonecrosis with bortezomib. Acta Haematol 118:203\u2013204","journal-title":"Acta Haematol"},{"key":"162_CR101","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdn630","volume":"20","author":"T Wyngaert Van den","year":"2009","unstructured":"Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E (2009) Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncol 20:331\u2013336","journal-title":"Ann Oncol"},{"key":"162_CR102","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4158\/EP.14.9.1150","volume":"14","author":"SJ Wimalawansa","year":"2008","unstructured":"Wimalawansa SJ (2008) Bisphosphonate-associated osteomyelitis of the jaw: guidelines for practicing clinicians. Endocr Pract 14:1150\u20131168","journal-title":"Endocr Pract"},{"key":"162_CR103","doi-asserted-by":"crossref","unstructured":"Taylor KH, Middlefell LS, Mizen KD (2010) Osteonecrosis of the jaws induced by anti-RANK ligand therapy. Br J Oral Maxillofac Surg (in press)","DOI":"10.1016\/j.bjoms.2009.08.030"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-010-0162-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-010-0162-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-010-0162-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T06:52:25Z","timestamp":1591167145000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-010-0162-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,24]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1007\/s00774-010-0162-7","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,24]]}}}